India Patient-derived Xenograft Model Market (2025-2031) | Companies, Segmentation, Competitive Landscape, Size & Revenue, Trends, Forecast, Outlook, Growth, Share, Value, Industry, Analysis

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 India Country Macro Economic Indicators

3.2 India Patient-derived Xenograft Model Market Revenues & Volume, 2021 & 2031F

3.3 India Patient-derived Xenograft Model Market - Industry Life Cycle

3.4 India Patient-derived Xenograft Model Market - Porter's Five Forces

3.5 India Patient-derived Xenograft Model Market Revenues & Volume Share, By Tumor Type, 2021 & 2031F

3.6 India Patient-derived Xenograft Model Market Revenues & Volume Share, By Model Type, 2021 & 2031F

3.7 India Patient-derived Xenograft Model Market Revenues & Volume Share, By End-user, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in India

4.2.2 Growing demand for personalized medicine and targeted therapies

4.2.3 Rising investments in healthcare research and development

4.3 Market Restraints

4.3.1 High cost associated with patient-derived xenograft models

4.3.2 Limited availability of skilled professionals for conducting research using PDX models

4.3.3 Stringent regulatory requirements for using animal models in research

6.1 India Patient-derived Xenograft Model Market, By Tumor Type

6.1.1 Overview and Analysis

6.1.2 India Patient-derived Xenograft Model Market Revenues & Volume, By Tumor Type, 2021- 2031F

6.1.3 India Patient-derived Xenograft Model Market Revenues & Volume, By Lung Cancer, 2021- 2031F

6.1.4 India Patient-derived Xenograft Model Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F

6.1.5 India Patient-derived Xenograft Model Market Revenues & Volume, By Prostate Cancer, 2021- 2031F

6.1.6 India Patient-derived Xenograft Model Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.1.7 India Patient-derived Xenograft Model Market Revenues & Volume, By Other Cancer, 2021- 2031F

6.2 India Patient-derived Xenograft Model Market, By Model Type

6.2.1 Overview and Analysis

6.2.2 India Patient-derived Xenograft Model Market Revenues & Volume, By Mice, 2021- 2031F

6.2.3 India Patient-derived Xenograft Model Market Revenues & Volume, By Rats, 2021- 2031F

6.3 India Patient-derived Xenograft Model Market, By End-user

6.3.1 Overview and Analysis

6.3.2 India Patient-derived Xenograft Model Market Revenues & Volume, By Pharmaceutical and Biopharmaceutical Companies, 2021- 2031F

6.3.3 India Patient-derived Xenograft Model Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F

6.3.4 India Patient-derived Xenograft Model Market Revenues & Volume, By CROs & CDMOs, 2021- 2031F

7.1 India Patient-derived Xenograft Model Market Export to Major Countries

7.2 India Patient-derived Xenograft Model Market Imports from Major Countries

8.1 Average turnaround time for generating patient-derived xenograft models

8.2 Number of collaborations between research institutions and pharmaceutical companies for PDX model research

8.3 Percentage of successful drug screenings using PDX models

8.4 Adoption rate of PDX models in preclinical research studies

9.1 India Patient-derived Xenograft Model Market Opportunity Assessment, By Tumor Type, 2021 & 2031F

9.2 India Patient-derived Xenograft Model Market Opportunity Assessment, By Model Type, 2021 & 2031F

9.3 India Patient-derived Xenograft Model Market Opportunity Assessment, By End-user, 2021 & 2031F

10.1 India Patient-derived Xenograft Model Market Revenue Share, By Companies, 2024

10.2 India Patient-derived Xenograft Model Market Competitive Benchmarking, By Operating and Technical Parameters